Skip to content
HowShorted

MGP Ingredients, Inc. short interest in 2022

In 2022, MGP Ingredients, Inc.'s disclosed short interest ran from 10.55% of shares outstanding on 14 Jan 2022 to 10.20% on 30 Dec 2022, a change of -0.35 percentage points. The year's high was 11.39% on 31 Oct 2022 and its low 8.68% on 15 Sep 2022, averaging 10.32% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.07 days on 15 Feb 2022. Full history: MGP Ingredients, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for MGP Ingredients, Inc. in 2022

2022 in figures

Start of year
10.55% (14 Jan 2022)
End of year
10.20% (30 Dec 2022)
Change
-0.35 pp
High
11.39% (31 Oct 2022)
Low
8.68% (15 Sep 2022)
Average
10.32%
Highest days to cover
30.07 (15 Feb 2022)
SEC filings marked
8

Every report in 2022

MGP Ingredients, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 202210.55%23.56
31 Jan 202210.62%22.01
15 Feb 202210.55%30.07
28 Feb 202210.59%24.1910-K filed, results (8-K)
15 Mar 202210.84%22.04
31 Mar 202210.76%28.61
14 Apr 202210.65%14.60
29 Apr 202210.56%21.47
13 May 202210.00%12.4610-Q filed, results (8-K)
31 May 202210.06%18.23
15 Jun 202210.38%16.97
30 Jun 202210.97%14.08
15 Jul 202210.61%17.08
29 Jul 202210.70%19.76
15 Aug 20229.42%13.1310-Q filed, results (8-K)
31 Aug 20228.78%18.70
15 Sep 20228.68%11.37
30 Sep 20229.10%9.54
14 Oct 202210.50%8.49
31 Oct 202211.39%17.66
15 Nov 202210.78%17.0810-Q filed, results (8-K)
30 Nov 202210.82%23.52
15 Dec 202210.27%20.95
30 Dec 202210.20%29.81

See also: MGP Ingredients, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.